NVST
Envista Holdings Corporation
NYSEUSDEQUITY
Healthcare
DELAYED
Neutral
-14/100
Last price
23.27
▼ 0.07 (0.30%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
23.34
Day high
23.75
Day low
23.11
Volume
1.84M
Market cap
$3.74B
P/E (TTM)
40.12
52W range
18.77 – 30.42
Trailing performance
Returnvs SPY
1W
-0.26%
-2.2%
1M
-14.70%
-15.9%
3M
-9.60%
-14.1%
6M
-7.99%
-26.2%
YTD
+7.19%
-7.1%
1Y
+11.61%
-4.8%
3Y
-16.54%
-98.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
10 more panels on NVST open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+240.29K
Net buying
Buy transactions
8
248.29K shares
Sell transactions
1
8.00K shares
Net transactions
+9
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
947.64K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 20, 26 | REIS MISCHA Officer |
SELL | 8.00K | $220.00K | Direct |
| Aug 18, 26 | KEEL PAUL A Chief Executive Officer |
STOCK | 179.73K | $0 | Direct |
| May 19, 26 | GALLAHUE KIERAN T. Director |
STOCK | 9.33K | $0 | Direct |
| May 19, 26 | RASKAS DANIEL A Director |
STOCK | 9.33K | $0 | Direct |
| May 19, 26 | TSINGOS CHRISTINE A Director |
STOCK | 9.33K | $0 | Direct |
| May 19, 26 | JAIN VIVEK Director |
STOCK | 9.33K | $0 | Direct |
| May 19, 26 | CARRUTHERS WENDY Director |
STOCK | 9.33K | $0 | Direct |
| May 19, 26 | HUENNEKENS R SCOTT Director |
STOCK | 12.59K | $0 | Direct |
| May 19, 26 | PIERCE JAMES ANDREW Director |
STOCK | 9.33K | $0 | Direct |
| Feb 25, 26 | HAMMES ERIC D. Chief Financial Officer |
STOCK | 16.05K | $0 | Direct |
| Feb 25, 26 | KEEL PAUL A Chief Executive Officer |
STOCK | 48.67K | $0 | Direct |
| Feb 25, 26 | NANCE MARK E General Counsel |
STOCK | 12.68K | $0 | Direct |
| Feb 25, 26 | REIS MISCHA Officer |
STOCK | 5.92K | $0 | Direct |
| Feb 25, 26 | KAABI FAEZ C Officer |
STOCK | 13.52K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ACURIO VERONICA |
Officer | 56.52K | Stock Award(Grant) |
CARRUTHERS WENDY |
Director | 59.94K | Stock Award(Grant) |
HAMMES ERIC D. |
Chief Financial Officer | 110.80K | Stock Award(Grant) |
HUENNEKENS R SCOTT |
Director | 82.11K | Stock Award(Grant) |
HULIT BARBARA B |
Director | 79.82K | Stock Award(Grant) |
KAABI FAEZ C |
Officer | 58.55K | Stock Award(Grant) |
KEEL PAUL A |
Chief Executive Officer | 551.30K | Stock Award(Grant) |
NANCE MARK E |
General Counsel | 81.25K | Stock Award(Grant) |
NILSSON STEFAN |
Officer | 62.36K | Stock Award(Grant) |
TSINGOS CHRISTINE A |
Director | 59.93K | Stock Award(Grant) |
Fundamentals
Market cap$3.74B
Enterprise value$4.20B
Revenue (TTM)$2.86B
Gross profit$1.58B
EBITDA$406.20M
Net income$95.00M
EPS (TTM)$0.58
Free cash flow$267.89M
Total cash$1.13B
Total debt$1.59B
Book value / share$19.16
Shares outstanding160.62M
Float159.87M
Short % of float7.14%
Dividend yield0.00%
Beta (5Y)0.89
Valuation & profitability ratios
Trailing P/E40.12
Forward P/E13.97
PEG ratio—
Price / sales—
Price / book1.21
EV / revenue1.47
EV / EBITDA10.34
Gross margin55.42%
Operating margin10.39%
Profit margin3.33%
Return on equity3.06%
Return on assets3.23%
Debt / equity51.62
Current ratio2.43
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.72B | $2.51B | $2.57B | $2.57B | +8.3% |
| Operating revenue | $2.72B | $2.51B | $2.57B | $2.57B | +8.3% |
| Cost of revenue | $1.23B | $1.14B | $1.13B | $1.09B | +8.3% |
| Gross profit | $1.49B | $1.37B | $1.44B | $1.47B | +8.3% |
| Research & development | $114.00M | $99.10M | $93.80M | $100.10M | +15.0% |
| Selling, general & admin | $1.14B | $1.14B | $1.03B | $1.03B | +0.0% |
| Total operating expense | $1.25B | $1.24B | $1.13B | $1.13B | +1.2% |
| Operating income | $235.80M | $137.20M | $314.90M | $343.20M | +71.9% |
| Net interest income | -$36.60M | -$46.40M | -$63.40M | -$38.40M | +21.1% |
| Pre-tax income | $177.20M | -$1.08B | -$54.90M | $283.90M | +116.3% |
| Tax provision | $130.20M | $33.90M | $45.30M | $45.90M | +284.1% |
| Net income | $47.00M | -$1.12B | -$100.20M | $243.10M | +104.2% |
| Net income to common | $47.00M | -$1.12B | -$100.20M | $243.10M | +104.2% |
| Basic EPS | 0.28 | -6.50 | -0.60 | 1.49 | +104.3% |
| Diluted EPS | 0.28 | -6.50 | -0.60 | 1.37 | +104.3% |
| EBIT | $213.80M | -$1.04B | $8.50M | $322.30M | +120.6% |
| EBITDA | $364.50M | -$883.80M | $171.10M | $484.40M | +141.2% |
| Basic shares | 168.00M | 172.20M | 166.90M | 162.90M | -2.4% |
| Diluted shares | 169.20M | 172.20M | 166.90M | 177.60M | -1.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.21B | $1.07B | $940.00M | $606.90M | — | +13.3% |
| Cash & short-term investments | $1.21B | $1.07B | $940.00M | $606.90M | — | +13.3% |
| Accounts receivable | $429.60M | $363.00M | $407.50M | $393.50M | — | +18.3% |
| Inventory | $288.10M | $241.00M | $258.80M | $300.80M | — | +19.5% |
| Total current assets | $2.03B | $1.79B | $1.74B | $1.42B | — | +13.3% |
| Property, plant & equipment | $438.90M | $419.80M | $434.70M | $425.40M | — | +4.5% |
| Goodwill & intangibles | $2.99B | $2.91B | $4.25B | $4.58B | — | +2.5% |
| Total assets | $5.68B | $5.35B | $6.61B | $6.59B | — | +6.1% |
| Total current liabilities | $852.60M | $878.70M | $780.80M | $1.24B | — | -3.0% |
| Current debt | — | $116.00M | $115.30M | $510.00M | $432.40M | — |
| Long-term debt | $1.45B | $1.28B | $1.40B | $870.70M | — | +13.3% |
| Total debt | $1.60B | $1.55B | $1.65B | $1.53B | — | +3.2% |
| Total liabilities | $2.57B | $2.42B | $2.43B | $2.38B | — | +6.5% |
| Retained earnings | -$440.40M | -$487.40M | $631.20M | $731.40M | — | +9.6% |
| Shareholder equity | $3.11B | $2.93B | $4.17B | $4.21B | — | +5.8% |
| Working capital | $1.17B | $909.60M | $962.90M | $187.90M | — | +29.1% |
| Net tangible assets | $120.90M | $23.00M | -$72.30M | -$376.40M | — | +425.7% |
| Shares issued | 175.40M | 174.20M | 173.30M | 163.70M | — | +0.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $47.00M | -$1.12B | -$100.20M | $243.10M | +104.2% |
| Depreciation & amortisation | $150.70M | $154.50M | $162.60M | $162.10M | -2.5% |
| Stock-based compensation | $37.60M | $35.30M | $30.70M | $30.50M | +6.5% |
| Change in working capital | $8.90M | $97.40M | -$71.40M | -$271.70M | -90.9% |
| Operating cash flow | $275.70M | $336.50M | $275.70M | $182.70M | -18.1% |
| Capital expenditure | -$45.30M | -$33.80M | -$58.20M | -$75.70M | -34.0% |
| Investing cash flow | -$51.10M | -$54.60M | -$62.40M | -$657.30M | +6.4% |
| Share buybacks | -$166.60M | $0 | $0 | — | — |
| Financing cash flow | -$170.90M | -$103.70M | $118.90M | $12.50M | -64.8% |
| Free cash flow | $230.40M | $302.70M | $217.50M | $107.00M | -23.9% |
| End cash position | $1.21B | $1.07B | $940.00M | $606.90M | +13.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $730.50M | $705.50M | $750.60M | $669.90M | $682.10M | +3.5% |
| Operating revenue | $730.50M | $705.50M | $750.60M | $669.90M | $682.10M | +3.5% |
| Cost of revenue | $323.50M | $315.40M | $340.00M | $299.70M | $312.20M | +2.6% |
| Gross profit | $407.00M | $390.10M | $410.60M | $370.20M | $369.90M | +4.3% |
| Research & development | $30.40M | $30.00M | $32.10M | $28.30M | $28.30M | +1.3% |
| Selling, general & admin | $296.30M | $293.90M | $285.50M | $284.40M | $295.30M | +0.8% |
| Total operating expense | $326.70M | $323.90M | $317.60M | $312.70M | $323.60M | +0.9% |
| Operating income | $80.30M | $66.20M | $93.00M | $57.50M | $46.30M | +21.3% |
| Net interest income | -$8.70M | -$7.40M | -$10.30M | -$9.00M | -$8.00M | -17.6% |
| Pre-tax income | $74.40M | $52.20M | $57.60M | $49.90M | $40.70M | +42.5% |
| Tax provision | $20.70M | $13.50M | $24.70M | $80.20M | $14.30M | +53.3% |
| Net income | $53.70M | $38.70M | $32.90M | -$30.30M | $26.40M | +38.8% |
| Net income to common | $53.70M | $38.70M | $32.90M | -$30.30M | $26.40M | +38.8% |
| Basic EPS | 0.33 | 0.24 | 0.20 | -0.18 | 0.16 | +37.5% |
| Diluted EPS | 0.33 | 0.23 | 0.20 | -0.18 | 0.16 | +43.5% |
| EBIT | $83.10M | $59.60M | $67.90M | $58.90M | $48.70M | +39.4% |
| EBITDA | $120.30M | $97.90M | $105.90M | $96.70M | $87.30M | +22.9% |
| Basic shares | 161.90M | 163.90M | 164.40M | 166.10M | 169.00M | -1.2% |
| Diluted shares | 164.10M | 166.40M | 166.00M | 166.10M | 169.90M | -1.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.13B | $1.08B | $1.21B | $1.13B | $1.11B | — | +4.0% |
| Cash & short-term investments | $1.13B | $1.08B | $1.21B | $1.13B | $1.11B | — | +4.0% |
| Accounts receivable | $436.90M | $436.60M | $429.60M | $405.90M | $422.80M | — | +0.1% |
| Inventory | $290.90M | $300.30M | $288.10M | $290.80M | $281.90M | — | -3.1% |
| Total current assets | $1.96B | $1.92B | $2.03B | $1.95B | $1.93B | — | +2.0% |
| Property, plant & equipment | $441.90M | $442.30M | $438.90M | $436.40M | $428.90M | — | -0.1% |
| Goodwill & intangibles | $2.97B | $2.99B | $2.99B | $3.01B | $3.04B | — | -0.9% |
| Total assets | $5.60B | $5.58B | $5.68B | $5.64B | $5.66B | — | +0.3% |
| Total current liabilities | $807.30M | $786.60M | $852.60M | $821.70M | $793.90M | — | +2.6% |
| Current debt | — | — | — | — | — | $116.20M | — |
| Long-term debt | $1.44B | $1.44B | $1.45B | $1.45B | $1.45B | — | -0.2% |
| Total debt | $1.59B | $1.59B | $1.60B | $1.60B | $1.60B | — | -0.1% |
| Total liabilities | $2.52B | $2.50B | $2.57B | $2.55B | $2.53B | — | +0.9% |
| Retained earnings | -$348.00M | -$401.70M | -$440.40M | -$473.30M | -$443.00M | — | +13.4% |
| Shareholder equity | $3.08B | $3.08B | $3.11B | $3.09B | $3.14B | — | -0.1% |
| Working capital | $1.15B | $1.13B | $1.17B | $1.13B | $1.14B | — | +1.6% |
| Net tangible assets | $109.50M | $86.70M | $120.90M | $79.70M | $103.30M | — | +26.3% |
| Shares issued | 160.60M | 176.20M | 175.40M | 175.30M | 175.00M | — | -8.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $53.70M | $38.70M | $32.90M | -$30.30M | $26.40M | +38.8% |
| Depreciation & amortisation | $37.20M | $38.30M | $38.00M | $37.80M | $38.60M | -2.9% |
| Stock-based compensation | $9.50M | $10.20M | $10.40M | $10.40M | $9.70M | -6.9% |
| Change in working capital | $20.20M | -$98.90M | $29.30M | $32.30M | $11.60M | +120.4% |
| Operating cash flow | $119.20M | -$3.30M | $108.00M | $78.70M | $88.70M | +3,712.1% |
| Capital expenditure | -$14.90M | -$12.50M | -$16.30M | -$10.80M | -$12.30M | -19.2% |
| Investing cash flow | -$14.30M | -$68.90M | -$15.50M | -$9.70M | -$17.10M | +79.2% |
| Share buybacks | -$60.30M | -$42.70M | -$24.30M | -$42.00M | -$85.70M | -41.2% |
| Financing cash flow | -$60.70M | -$45.60M | -$25.20M | -$41.70M | -$86.40M | -33.1% |
| Free cash flow | $104.30M | -$15.80M | $91.70M | $67.90M | $76.40M | +760.1% |
| End cash position | $1.13B | $1.08B | $1.21B | $1.13B | $1.11B | +4.0% |
Options analytics
Put / call volume
3.14
Put-heavy session
Put / call open interest
0.30
Positioning, not flow
Max pain
22.50
-3.3% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
-6.2%
Calls bid over puts
Call volume
14
Contracts, this expiry
Put volume
44
Contracts, this expiry
Heaviest call OI
22.50
100 contracts
Heaviest put OI
22.50
44 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.34 | 0.41 | +22.2% |
| Mar 2026 | 0.31 | 0.36 | +15.2% |
| Dec 2025 | 0.32 | 0.38 | +17.7% |
| Sep 2025 | 0.28 | 0.32 | +16.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.36 | 15 | $689.81M | +3.0% |
| Next quarter | 0.41 | 15 | $753.55M | +0.4% |
| Current year | 1.53 | 15 | $2.88B | +5.8% |
| Next year | 1.67 | 15 | $2.98B | +3.6% |
Analyst targets & ownership
Mean target$29.69
High target$35.00
Low target$23.00
Implied upside27.60%
Analyst count13
ConsensusBUY
Strong buy / Buy2 / 6
Hold7
Sell / Strong sell0 / 0
Held by insiders0.59%
Held by institutions120.05%
Institutions holding518
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
23.56
-1.23% from price
SMA 20
24.18
-3.76% from price
SMA 50
26.25
-11.34% from price
SMA 100
25.69
-9.42% from price
SMA 200
25.68
-9.37% from price
EMA 12
23.73
-1.94% from price
EMA 26
24.60
-5.39% from price
EMA 50
25.35
-8.22% from price
RSI (14)
34.0
Neutral
MACD (12,26,9)
-0.86
Hist 0.01
ATR (14)
0.68
2.91% of price
Realised vol 30D
27.6%
Annualised
Bollinger upper
26.15
20, 2σ
Bollinger lower
22.21
20, 2σ
50 / 200 cross
Golden
26.25 vs 25.68
Trend bias
Below 200
-9.37%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.19
More volatile than market
Correlation to SPY
0.41
Loosely linked
Realised vol 30D
27.6%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-26.0%
Peak to trough
Max drawdown 5Y
-71.0%
Peak to trough
ATR 14
0.68
2.91% of price
Beta (reported)
0.89
5Y monthly, from filing
Short interest
Shares short
10.21M
Prior 9.63M
Change vs prior
+6.0%
Shorts adding
% of float
7.14%
Normal
% of shares out
6.36%
Against total outstanding
Days to cover
4.4
Liquid
Float
159.87M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 28, 26 | BMO Capital | MAINTAINED | Market Perform | Market Perform |
| Sep 18, 26 | Piper Sandler | MAINTAINED | Neutral | Neutral |
| Sep 18, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Sep 18, 26 | Needham | MAINTAINED | Hold | Hold |
| Sep 3, 26 | JP Morgan | UPGRADE | Neutral | Overweight |
| Aug 6, 26 | Piper Sandler | MAINTAINED | Neutral | Neutral |
| Jul 29, 26 | Piper Sandler | MAINTAINED | Neutral | Neutral |
| Jul 9, 26 | BMO Capital | INITIATED | — | Market Perform |
| Jun 11, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| May 7, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| May 7, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| May 7, 26 | Baird | MAINTAINED | Outperform | Outperform |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-17
Corporate Changes & Voting Matters
8-K · 2026-08-19
Corporate Changes & Voting Matters
8-K · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-06-03
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-28
Corporate Changes & Voting Matters
8-K · 2026-05-21
Corporate Changes & Voting Matters
8-K · 2026-05-06
Annual Report to Shareholders
ARS · 2026-04-07
Headlines
Envista Schedules Third Quarter 2026 Earnings Call
PR Newswire · 15h ago
1 of Wall Street’s Favorite Stocks to Keep an Eye On and 2 We Ignore
StockStory · 5d ago
Leaner Operations and Improving Dental Demand Position Envista Holdings Corp. (NVST) for Multi-Year Growth
Insider Monkey · 6d ago
Dental Equipment & Technology Stocks Q2 Earnings Review: Envista (NYSE:NVST) Shines
StockStory · 7d ago
New Strong Buy Stocks for September 28th
Zacks · 9d ago
NVST vs. ABT: Which Stock Is the Better Value Option?
Zacks · 12d ago
Envista Holdings (NVST), Why Is Investor Attention Building Now?
Simply Wall St. · 15d ago
Best Value Stocks to Buy for September 21st
Zacks · 16d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.